Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Crinetics Pharmaceuticals

7 clinical trials

Clinical trial
An Open Label, Long-term Extension Study to Evaluate the Safety and Efficacy of CRN00808 in Subjects With Acromegaly (ACROBAT Advance)
Status: Active (not recruiting), Estimated PCD: 2028-03-01
Clinical trial
A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects With Acromegaly Treated With Long-acting Somatostatin Receptor Ligands (PATHFNDR-1)
Status: Active (not recruiting), Estimated PCD: 2023-07-10
Clinical trial
A Randomized, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects With Non-pharmacologically Treated Acromegaly (PATHFNDR-2)
Status: Active (not recruiting), Estimated PCD: 2024-01-20
Clinical trial
A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects With Carcinoid Syndrome
Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)
Status: Recruiting, Estimated PCD: 2026-10-01
Clinical trial
A 12-week, Phase 2 Open-label, Sequential Dose Cohort Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 Treatment in Participants With Congenital Adrenal Hyperplasia (TouCAHn)
Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Double-blind, Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CRN04894 in Healthy Volunteers
Status: Completed, Estimated PCD: 2022-04-11